IL177232A0 - Heteroarylaminopyrazole derivatives useful for the treatment of diabetes - Google Patents
Heteroarylaminopyrazole derivatives useful for the treatment of diabetesInfo
- Publication number
- IL177232A0 IL177232A0 IL177232A IL17723206A IL177232A0 IL 177232 A0 IL177232 A0 IL 177232A0 IL 177232 A IL177232 A IL 177232A IL 17723206 A IL17723206 A IL 17723206A IL 177232 A0 IL177232 A0 IL 177232A0
- Authority
- IL
- Israel
- Prior art keywords
- heteroarylaminopyrazole
- diabetes
- treatment
- derivatives useful
- derivatives
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54833104P | 2004-02-27 | 2004-02-27 | |
| US57290604P | 2004-05-20 | 2004-05-20 | |
| PCT/US2005/005794 WO2005086656A2 (en) | 2004-02-27 | 2005-02-24 | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL177232A0 true IL177232A0 (en) | 2006-12-10 |
Family
ID=34976070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL177232A IL177232A0 (en) | 2004-02-27 | 2006-08-02 | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7517878B2 (en) |
| EP (1) | EP1720863A4 (en) |
| JP (1) | JP2007525513A (en) |
| KR (1) | KR20060124727A (en) |
| AR (1) | AR049418A1 (en) |
| AU (1) | AU2005220723A1 (en) |
| BR (1) | BRPI0508051A (en) |
| CA (1) | CA2557527A1 (en) |
| EC (1) | ECSP066883A (en) |
| IL (1) | IL177232A0 (en) |
| MA (1) | MA28479B1 (en) |
| NO (1) | NO20064325L (en) |
| PE (1) | PE20051159A1 (en) |
| RU (1) | RU2006134004A (en) |
| TW (1) | TW200538130A (en) |
| UY (1) | UY28774A1 (en) |
| WO (1) | WO2005086656A2 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005306458B2 (en) | 2004-11-17 | 2011-02-17 | Miikana Therapeutics, Inc. | Kinase inhibitors |
| WO2006065590A2 (en) * | 2004-12-16 | 2006-06-22 | Xtl Biopharmaceuticals Inc. | Pyridine and pyrimidine antiviral compositions |
| JP5140577B2 (en) | 2005-03-31 | 2013-02-06 | タケダ カリフォルニア インコーポレイテッド | Hydroxysteroid dehydrogenase inhibitor |
| NZ567241A (en) * | 2005-09-30 | 2010-08-27 | Miikana Therapeutics Inc | Substituted pyrazole compounds |
| CA2647208C (en) * | 2006-03-24 | 2014-05-13 | Array Biopharma Inc. | Glucokinase activators |
| SA08280783B1 (en) * | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | Pyridopyrimidine Derivatives as PDE4 Inhibitors |
| JP5450108B2 (en) * | 2007-03-23 | 2014-03-26 | アレイ バイオファーマ、インコーポレイテッド | 2-Aminopyridine analogues as glucokinase activators |
| AU2008262291A1 (en) * | 2007-06-11 | 2008-12-18 | Miikana Therapeutics, Inc. | Substituted pyrazole compounds |
| UA101166C2 (en) | 2007-09-21 | 2013-03-11 | Аррей Биофарма Инк. | Pyridin-2-yl-amino-1,2,4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
| US9315449B2 (en) | 2008-05-15 | 2016-04-19 | Duke University | Substituted pyrazoles as heat shock transcription factor activators |
| EP2135865A1 (en) | 2008-06-17 | 2009-12-23 | Bayer CropScience AG | Substituted 1-(diazinyl)pyrazol-4-yl acetic acids, method for their production and their use as herbicides and plant growth regulators |
| DE102008039082A1 (en) | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Azabicyclic-substituted 5-aminopyrazoles and their use |
| DE102008039083A1 (en) * | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Substituted 5-aminopyrazoles and their use |
| EP2194052A1 (en) | 2008-12-06 | 2010-06-09 | Bayer CropScience AG | Substituted 1.(1-thiazolyl)- and 1-(isothiazolyl)pyrazol-4-yl acetic acids, method for their production and their use as herbicides and plant growth regulators |
| KR102097664B1 (en) * | 2009-10-06 | 2020-04-06 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Heterocyclic Compounds Useful as PDK1 Inhibitors |
| WO2011073098A1 (en) | 2009-12-15 | 2011-06-23 | Bayer Cropscience Ag | 1-(heteroaryl)-pyrazol-4-yl-acetic acids, method for the production thereof, and the use thereof as herbicides and plant growth regulators |
| WO2017156493A1 (en) | 2016-03-11 | 2017-09-14 | Denali Therapeutics Inc. | Compounds, compositions, and methods |
| EP3194377A4 (en) * | 2014-09-17 | 2018-04-18 | Epizyme, Inc. | Heterocycle substituted amino-pyridine compounds and methods of use thereof |
| WO2016092559A1 (en) * | 2014-12-12 | 2016-06-16 | Oat & Iil India Laboratories Private Limited | Substituted pyrazole derivatives having activity as fungicides |
| WO2017087905A1 (en) | 2015-11-20 | 2017-05-26 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| KR101725292B1 (en) * | 2016-03-30 | 2017-04-10 | 한국과학기술연구원 | Novel Pyrimidine-4-Carboxylic Acid Derivatives Having Anti-tumor Activity |
| SG10201912632YA (en) | 2016-06-16 | 2020-02-27 | Denali Therapeutics Inc | Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4405207A1 (en) * | 1994-02-18 | 1995-08-24 | Bayer Ag | N-pyrazolylanilines and N-pyrazolylaminopyridines |
| US20020103185A1 (en) * | 2000-08-31 | 2002-08-01 | Sanner Mark A. | Pyrazole derivatives |
| US6660731B2 (en) * | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US7319102B1 (en) * | 2003-12-09 | 2008-01-15 | The Procter & Gamble Company | Pyrrolo[2,3-d]pyrimidine cytokine inhibitors |
-
2005
- 2005-02-21 AR ARP050100628A patent/AR049418A1/en unknown
- 2005-02-24 CA CA002557527A patent/CA2557527A1/en not_active Abandoned
- 2005-02-24 KR KR1020067017159A patent/KR20060124727A/en not_active Withdrawn
- 2005-02-24 WO PCT/US2005/005794 patent/WO2005086656A2/en not_active Ceased
- 2005-02-24 AU AU2005220723A patent/AU2005220723A1/en not_active Abandoned
- 2005-02-24 JP JP2007500954A patent/JP2007525513A/en active Pending
- 2005-02-24 US US11/064,700 patent/US7517878B2/en not_active Expired - Fee Related
- 2005-02-24 EP EP05723606A patent/EP1720863A4/en not_active Withdrawn
- 2005-02-24 RU RU2006134004/04A patent/RU2006134004A/en not_active Application Discontinuation
- 2005-02-24 BR BRPI0508051-7A patent/BRPI0508051A/en not_active IP Right Cessation
- 2005-02-25 PE PE2005000226A patent/PE20051159A1/en not_active Application Discontinuation
- 2005-02-25 TW TW094105697A patent/TW200538130A/en unknown
- 2005-02-25 UY UY28774A patent/UY28774A1/en not_active Application Discontinuation
-
2006
- 2006-08-02 IL IL177232A patent/IL177232A0/en unknown
- 2006-09-22 MA MA29334A patent/MA28479B1/en unknown
- 2006-09-25 NO NO20064325A patent/NO20064325L/en not_active Application Discontinuation
- 2006-09-26 EC EC2006006883A patent/ECSP066883A/en unknown
-
2009
- 2009-04-13 US US12/422,804 patent/US20090209451A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AR049418A1 (en) | 2006-08-02 |
| KR20060124727A (en) | 2006-12-05 |
| EP1720863A4 (en) | 2009-04-22 |
| UY28774A1 (en) | 2005-08-31 |
| US7517878B2 (en) | 2009-04-14 |
| MA28479B1 (en) | 2007-03-01 |
| EP1720863A2 (en) | 2006-11-15 |
| ECSP066883A (en) | 2006-11-24 |
| AU2005220723A1 (en) | 2005-09-22 |
| US20050192294A1 (en) | 2005-09-01 |
| WO2005086656A3 (en) | 2005-12-29 |
| TW200538130A (en) | 2005-12-01 |
| WO2005086656A2 (en) | 2005-09-22 |
| CA2557527A1 (en) | 2005-09-22 |
| RU2006134004A (en) | 2008-04-10 |
| PE20051159A1 (en) | 2006-02-22 |
| NO20064325L (en) | 2006-11-22 |
| JP2007525513A (en) | 2007-09-06 |
| US20090209451A1 (en) | 2009-08-20 |
| BRPI0508051A (en) | 2007-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL177232A0 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
| IL191832A0 (en) | Pyridiazinone derivatives for the treatment of tumours | |
| ZA200706791B (en) | Isoxazole combretasin derivatives for the treatment of disorders | |
| SI1802579T1 (en) | Derivatives of 3-arylaminopyridine | |
| ZA200706294B (en) | Roflumilast for the treatment of diabetes mellitus | |
| AP2007004157A0 (en) | N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain | |
| IL184934A0 (en) | 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases | |
| ZA200704154B (en) | Substituted benzoquinolizines as DPP-IV inhibitors for the treatment of diabetes | |
| ZA200706113B (en) | Method for the treatment of copper-bearing materials | |
| PL377164A1 (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| EP1809265A4 (en) | Methods for the treatment of synucleinopathies | |
| IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
| IL190965A0 (en) | Processes for the preparation of cyclopropyl-amide derivatives | |
| IL189928A0 (en) | Thiophene derivatives for the treatment of diabetes | |
| EP1753446A4 (en) | Alpha-1- acid glycoprotein for the treatment of diabetes | |
| EP1750698A4 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
| GB0400802D0 (en) | Compounds for the treatment of disease | |
| PL1959957T3 (en) | Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis | |
| IL177673A0 (en) | Benzopyran compound useful for the treatment of arrhythmia | |
| IL179670A0 (en) | Heterocyclic compounds and processes for the preparation thereof | |
| EP1718294A4 (en) | Methods for treatment of complications of diabetes | |
| ZA200608015B (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
| GB0423173D0 (en) | Treatment of diabetes | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| HU0400847D0 (en) | Pharmaceutical composition for the treatment of diabetes |